Zhimeng Biopharma EN | 简体
Zhimeng Biopharma

  • Home
  • About Us
  • People
    • Leadership Team
    • Scientific Advisors
  • Pipeline
  • News
  • Investors
  • Join Us
  • Contact

People

Management Team


Jessie Jiang, Ph.D.

Jessie Jiang, Ph.D.

Senior medical director
Ruoling Guo, Ph.D.

Ruoling Guo, Ph.D.

Senior Director, Global clinical operations
Gang Liu, Ph.D.

Gang Liu, Ph.D.

Director, Chemistry, Manufacturing and Controls (CMC)
Bo Hua, M.S.

Bo Hua, M.S.

Director, Preclinical Pharmacology and Toxicology
Tian Xia, Ph.D.

Tian Xia, Ph.D.

Senior Scientist
Hualin Wang, Ph.D.

Hualin Wang, Ph.D.

Senior Scientist
Haosi Huang, M.D., Ph.D.

Haosi Huang, M.D., Ph.D.

Senior Research Scientist
Hui Lu, Ph.D.

Hui Lu, Ph.D.

Senior Project Manager

Get in touch

Contact Us About Us Leadership Team Scientific Advisors
Quick Links
  • About Us
  • Contact Us
  • Join Us
  • Pipeline
  • Leadership Team
  • Scientific Advisors
Recent News
  • Zhimeng’s Innovative HBV Core Protein-Targeted Drug Reached Agreement with CDE for Initiating the Phase 3 Clinical Trial
  • Zhimeng Biopharma CB03 Received Orphan Drug Designation from the US FDA - A Potassium Ion Channel Opener for Amyotrophic Lateral Sclerosis
  • Zhimeng Biopharma Entered into A Global Exclusive Licensing Agreement with GlaxoSmithKline in HBV

© 2025 Zhimeng Biopharma. All Rights Reserved. 备案号:沪ICP备18045542号-1 | 沪公网安备 31011502011190号

© 2025 Zhimeng Biopharma. All Rights Reserved.